The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy | Zendy

Mia C. Borlongan | Zendy; Maximillian C. Borlongan | Zendy; Paul R. Sanberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy

Author(s) -

Mia C. Borlongan,

Maximillian C. Borlongan,

Paul R. Sanberg

Publication year - 2020

Publication title -

cell transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.043

H-Index - 100

eISSN - 1555-3892

pISSN - 0963-6897

DOI - 10.1177/0963689720940719

Subject(s) - convalescent plasma , covid-19 , medicine , limiting , disease , intensive care medicine , coronavirus , immune system , contagious disease , virus , inflammation , immunology , infectious disease (medical specialty) , virology , outbreak , mechanical engineering , engineering

Coronavirus disease 2019 or COVID-19 is highly infectious, which can lead to acute and chronic debilitating symptoms, as well as mortality. The advent of safe and effective vaccines or antiviral drugs remains distant in the future. Practical public health measures, such as social distancing, hand washing, and wearing a face mask, are the current recommended guidelines by the Centers for Disease Control and Prevention for limiting the spread of the virus. Weakened immune system and aberrant inflammation represent a major pathological symptom of COVID-19 patients. Based on the unique immunomodulatory properties of both convalescent plasma and stem cells, we discuss here their potential use for treating COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research